683 Capital Management, LLC Hille Vax, Inc. Transaction History

683 Capital Management, LLC

  • $1.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.86 - $15.93 $320,220 - $430,110
27,000 Added 23.89%
140,000 $2.02 Million
Q1 2024

May 15, 2024
SELL
$14.15 - $19.75 $116,030 - $161,950
-8,200 Reduced 6.77%
113,000 $1.88 Million
Q3 2023

Nov 14, 2023
BUY
$11.59 - $16.7 $1.4 Million - $2.02 Million
121,200 New
121,200 $1.63 Million

Others Institutions Holding HLVX

# of Institutions
78
Shares Held
36.1M
Call Options Held
0
Put Options Held
0
View Full List

About HilleVax, Inc.

HLVX Quotes by TradingView
  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $65.9M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email